Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by AXQ Capital LP

AXQ Capital LP lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 33.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,975 shares of the company’s stock after selling 2,015 shares during the quarter. AXQ Capital LP’s holdings in Henry Schein were worth $275,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. FMR LLC lifted its holdings in Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after purchasing an additional 237,888 shares during the period. Southpoint Capital Advisors LP lifted its holdings in Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after acquiring an additional 600,000 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Henry Schein by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock valued at $82,464,000 after acquiring an additional 16,616 shares during the last quarter. ING Groep NV lifted its holdings in Henry Schein by 34.1% in the 4th quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock valued at $80,486,000 after acquiring an additional 295,785 shares during the last quarter. Finally, Stifel Financial Corp lifted its holdings in Henry Schein by 1.2% in the 3rd quarter. Stifel Financial Corp now owns 1,122,455 shares of the company’s stock valued at $81,827,000 after acquiring an additional 13,180 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Henry Schein Price Performance

Shares of HSIC opened at $69.39 on Monday. The company has a market capitalization of $8.62 billion, a price-to-earnings ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business’s 50-day moving average is $74.82 and its 200-day moving average is $72.64.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 EPS. Equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of a number of research analyst reports. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.